The Orthopedic Market in 2 Minutes

As you enter orthopedic residency, you’re stepping into one of the largest procedural specialties in medicine — clinically and economically.

Globally, the orthopedic device and technology market is estimated to be about $60–65 billion per year, with projections to exceed $80–100 billion over the next decade.

Unlike some areas of healthcare, orthopedic growth is driven less by price increases and more by:

• Increasing surgical case volume
• Aging and more active patient populations
• Technological innovation
• Migration of procedures to outpatient surgery centers

Major Areas of the Orthopedic Market

Joint Reconstruction (Largest Segment)

Hip, knee, and shoulder replacement procedures represent roughly 35–45% of orthopedic revenue globally, translating to an estimated $22–28 billion annual market.

This is the most standardized and hospital-system driven part of the specialty, with large multinational companies dominating market share.

Example companies:

• Stryker Joint Replacement
• Zimmer Biomet
• DePuy Synthes (Johnson & Johnson)
• Smith & Nephew

Trauma & Extremities

Fracture fixation and small bone reconstruction account for approximately 15–20% of the market, or about $10–13 billion globally.

This segment is typically more surgeon-preference driven, innovation focused, and distributor influenced compared to large joint replacement.

Example companies:

• DePuy Synthes Trauma
• Stryker Trauma & Extremities
• Zimmer Biomet Trauma

Spine Surgery

Spine implants and enabling technologies represent an estimated $10–12 billion global market.

This is one of the most technology-intensive areas of musculoskeletal care, with continued evolution toward minimally invasive surgery and outpatient spine procedures.

Example companies:

• Medtronic
• Globus Medical
• Alphatec Spine
• DePuy Synthes Spine
• NuVasive (now part of Globus Medical)

Sports Medicine & Arthroscopy

Sports medicine represents roughly a $6–8 billion market, including soft-tissue fixation, arthroscopic implants, and biologic adjunct technologies.

Growth is supported by younger active patients, return-to-sport expectations, and expanding indications for minimally invasive procedures.

Example companies:

• Arthrex
• Smith & Nephew Sports Medicine
• Stryker Endoscopy & Sports Medicine
• ConMed

Orthobiologics

Orthobiologics — including bone graft substitutes, cellular allografts, and regenerative scaffolds — represent an estimated $3–5 billion market, but with some of the fastest projected growth rates in orthopedics.

This segment is increasingly influencing fusion rates, healing timelines, and surgical decision-making.

Example companies:

• Medtronic Biologics
• Orthofix
• Bioventus
• BoneSupport
• Organogenesis

Orthopedic Instruments & Enabling Technology

Enabling technologies such as robotics, navigation systems, power tools, and disposable surgical systems account for roughly $8–10 billion globally.

These technologies are rapidly expanding due to the push for efficiency, reproducibility, and outpatient surgical workflows.

Example companies:

• Stryker (Mako robotic platform)
• Zimmer Biomet (Rosa robotics)
• Smith & Nephew (Cori robotics)
• DePuy Synthes Velys system

Why This Matters

The business structure of orthopedics influences:

• Fellowship demand
• Practice opportunities
• Research funding
• Technology adoption
• Industry collaboration

Understanding the industry early in training gives you a strategic advantage as you shape your career path.